# Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction.

> **NCT00639912** · PHASE4 · COMPLETED · sponsor: **Azienda USL Reggio Emilia - IRCCS** · enrollment: 599 (actual)

## Conditions studied

- Contrast Induced Nephropathy

## Interventions

- **DRUG:** sodium chloride
- **DRUG:** sodium chloride
- **DRUG:** sodium bicarbonate
- **DRUG:** sodium bicarbonate

## Key facts

- **NCT ID:** NCT00639912
- **Lead sponsor:** Azienda USL Reggio Emilia - IRCCS
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2010-05
- **Final completion:** 2010-10
- **Target enrollment:** 599 (ACTUAL)
- **Last updated:** 2025-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00639912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00639912, "Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00639912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*